Page 6 - Pharmaceuticals
Glenmark receives US FDA nod for cholesterol-lowering drug fenofibrate
The approved product - fenofibrate capsule - is a generic version of AbbVie's Tricor capsule
 "Glenmark receives US FDA nod for cholesterol-lowering drug fenofibrate")
Fresenius Kabi in talks with Akorn for takeover
Akorn has five manufacturing facilities - three in US and one each in Switzerland & India
 "Fresenius Kabi in talks with Akorn for takeover")
US FDA agrees to fast track trial process for Wockhardt's superdrug
Wockhardt to start phase III clinical trial for antibiotic WCK 5222, used for treating superbug
 "US FDA agrees to fast track trial process for Wockhardt's superdrug")
Eli Lilly plans $ 850 million investment for expansion in US
To invest $85 mn to expand its Trulicity (dulaglutide) device assembly operations in Indianapolis
 "Eli Lilly plans $ 850 million investment for expansion in US")
Dr Reddy's Labs to market US-based Integra's neurological products in India
It will distribute Integra's DuraGen Plus and Suturable DuraGen Dural Regeneration in the country
 "Dr Reddy's Labs to market US-based Integra's neurological products in India")
Lupin receives US FDA approval for tobramycin inhalation solution
The product is Lupin's first generic approval in the inhalation space
 "Lupin receives US FDA approval for tobramycin inhalation solution")
Piramal Pharma Solutions expands sterile manufacturing facility in US
The company to invest $25 mn to expand its manufacturing capability in phases
 "Piramal Pharma Solutions expands sterile manufacturing facility in US")
BeiGene & Guangzhou Development District to set up $ 330 mn biologics plant
JV will also provide funding for research and development of biologic drug candidates in China
 "BeiGene & Guangzhou Development District to set up $ 330 mn biologics plant")
Unichem Laboratories receives US FDA approval for migraine drug
It has received approval for rizatriptan benzoate ODT & rizatriptan benzoate tablets
 "Unichem Laboratories receives US FDA approval for migraine drug")
Global orphan drugs market to reach $ 209 billion by 2022
The market is set to be 21.4% of worldwide prescription sales by 2022, says Evaluate report
 "Global orphan drugs market to reach $ 209 billion by 2022")
Merck's arm Allergopharma opens biopharmaceutical facility in Germany
New production unit, built with an investment of € 42 mn, to expand the company's global capability
 "Merck's arm Allergopharma opens biopharmaceutical facility in Germany")
Zydus settles patent litigation related to seizure drug with US-based firm
As per the pact, Zydus to begin selling a generic version of Supernus' Trokendi XR on Jan 1, 2023
Cadila Healthcare's Baddi unit receives 3 observations under Form 483
Observations, given by US FDA, are related to pre-approval inspection for a specific product filed
 "Cadila Healthcare's Baddi unit receives 3 observations under Form 483")
Valeant increases Salix sales force by 40% to capture untapped market
It will make investment in primary care representatives for key products such as Xifaxan & Relistor
 "Valeant increases Salix sales force by 40% to capture untapped market")
Zydus Cadila to launch tetravalent influenza vaccine in India
Vaccine offers protection from 4 influenza viruses - H1N1, H3N2, Type B (Brisbane) & Type B (Phuket)
 "Zydus Cadila to launch tetravalent influenza vaccine in India")
Zydus receives US FDA approval for anti-viral drug oseltamivir
The group has also received the US drug regulator's nod to market anti-bacterial drug, linezolid
 "Zydus receives US FDA approval for anti-viral drug oseltamivir")
Sanofi & Lonza to jointly set up $ 285-mn biologics production facility
The facility, to be built in Switzerland, is expected to be fully operational by 2020
 "Sanofi & Lonza to jointly set up $ 285-mn biologics production facility")
Lupin arm Kyowa inks pact with Astellas Pharma to sell antidepressant drug
As per the deal, Kyowa will exclusively market Astellas' quetiapine fumarate tablet in Japan
 "Lupin arm Kyowa inks pact with Astellas Pharma to sell antidepressant drug")
Arrival of foreign tourists on medical visa witnessing phenomenal growth
Indian pharma market to reach $ 55 bn by 2020 from $ 36.7 bn in 2016, says Assocham-IITTM study
 "Arrival of foreign tourists on medical visa witnessing phenomenal growth")
US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim
The proposed biosimilar is used to reduce the duration of neutropenia (low count of neutrophils)
 "US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim")
